SS
The startup develops organoid culture technology utilizing human pancreatic cancer cell lines to create a mouse model that enables high-throughput drug efficacy testing. This approach facilitates early diagnosis and treatment options for pancreatic cancer patients by rapidly evaluating potential therapies.
Updated 4 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops organoid culture technology utilizing human pancreatic cancer cell lines to create a mouse model that enables high-throughput drug efficacy testing. This approach facilitates early diagnosis and treatment options for pancreatic cancer patients by rapidly evaluating potential therapies.